Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

MeiraGTx Holdings plc (MGTX)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
19.76-0.11 (-0.55%)
At close: 4:00PM EST
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close19.87
Open19.70
Bid19.00 x 900
Ask19.80 x 2200
Day's Range19.07 - 19.91
52 Week Range11.60 - 23.15
Volume225,758
Avg. Volume327,053
Market Cap875.014M
Beta (5Y Monthly)1.30
PE Ratio (TTM)N/A
EPS (TTM)-1.67
Earnings DateAug 04, 2021 - Aug 09, 2021
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est35.57
  • Zacks

    MeiraGTx Holdings PLC (MGTX) Reports Q3 Loss, Tops Revenue Estimates

    MeiraGTx Holdings PLC (MGTX) delivered earnings and revenue surprises of -13.46% and 38.94%, respectively, for the quarter ended September 2021. Do the numbers hold clues to what lies ahead for the stock?

  • GlobeNewswire

    MeiraGTx Reports Third Quarter 2021 Financial and Operational Results

    LONDON and NEW YORK, Nov. 10, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (Nasdaq: MGTX), a vertically integrated, clinical stage gene therapy company, today announced financial results for the third quarter ended September 30, 2021 and provided an update on recent progress. During the quarter, MeiraGTx continued to progress the Phase 3 Lumeos Trial of botaretigene sparoparvovec, formerly referred to as AAV5-RPGR, in X-linked retinitis pigmentosa (XLRP) with its partner Janssen Pharmaceutical

  • GlobeNewswire

    MeiraGTx to Participate in Upcoming Virtual Investor Conferences

    LONDON and NEW YORK, Nov. 09, 2021 (GLOBE NEWSWIRE) -- MeiraGTx Holdings plc (NASDAQ:MGTX), a vertically integrated, clinical stage gene therapy company, today announced that Alexandria Forbes, Ph.D., President and Chief Executive Officer, will participate in the following virtual investor conferences: Barclays Gene Editing & Gene Therapy Summit Corporate presentation: Monday, November 15, 2021, at 2:00 p.m. ET 33rd Annual Piper Sandler Healthcare Conference Fireside chat: available from Monday

Advertisement
Advertisement